Page results
-
A new gene therapy to treat Huntington’s disease has shown positive data from the study of AMT-130 which is being run at UCLH and other sites.
-
We’re proud that UCLH is ranked number one of all acute teaching trusts in new national league tables published today.
-
The stroke team at the National Hospital for Neurology and Neurosurgery (NHNN) is the first in the NHS to carry out implants on cryptogenic stroke patients rather than refer them to a cardiology service.
-
North Mid, UCLH and Whittington Health are running a fun, uplifting, informative event for people with sickle cell on Saturday 25th June 2022.
-
October is free wills month. We have partnered with Octopus Legacy and are pleased to offer a free will writing service to all our supporters.
-
CTOS 2023 Dublin Physicians, residents, colleagues, and healthcare professionals who specialize in sarcomas come together during this meeting to discuss new developments, treatments, and advancements in the field.
-
Nailesh Rambhai became an associate non-executive director at UCLH in April 2022. A lawyer by background, he has also acted as group counsel and company secretary to a number of firms including the Coventry Building Society and Petronas.
-
Our staff have rated UCLH as the top trust in London to work at, and the third best in the country, during what has been another incredibly challenging year.
-
A new specialist blood transfusion service at Luton and Dunstable University Hospital is transforming care for people living with sickle cell disease (SCD) across the East of England.
-
Two clinicians with close links to UCLH and UCL have been appointed to be National Clinical Directors (NCD) by NHS England (NHSE) for 2024.
File results
-
FOI/2024/0628 - Service personnel/ armed force families access to speech and language therapy for children who stammer
-
FOI/2024/0633 - Adults, children diagnosed/ living with Glycogen storage disease type V (Mcardle's disease)
-
FOI/2024/0635 - Patient incidences/ injuries due to chiropractic treatment
-
FOI/2024/0648 - Performance management Policy for July 2020 to November 2022
-
FOI/2024/0651 - Family history units/ familial cancer services
-
FOI/2024/0652 - Overseas visitors invoiced in 2023/24
-
FOI/2024/0662 - Treatment of haematology/ Myeloprolifeative diseases/ Non Hodgkin Lymphoma/ Chronic Lymphocytic Leukaemia/ Mantle Cell Lymphoma
-
FOI/2024/0663 - Diagnosis discharge codes and cases 2018-19 to 2022-23
-
FOI/2024/0667 - Agency/ bank staff, master/neutral vendor/ contract and contact details 2023/24
-
FOI/2024/0668 - Doctors shifts covered by Physician Associates 01/04/2024-01/09/2024